We're proud to share that our portfolio company PreComb has been named a finalist for the 2025 Responsible Investment, Sustainability, and ESG (RISE) Awards in the Healthcare category.
Organized by Sustainable Times, the RISE Awards recognize pioneering organizations that drive positive change across industries. PreComb is being honored alongside fellow finalists 2cureX and Nurtify for its transformative work in precision oncology.
PreComb's platform predicts patient drug response to help clinicians tailor cancer treatments with greater confidence. By reducing the time, cost, and uncertainty that often accompany treatment selection, PreComb is making personalized oncology more accessible and actionable for patients who need it most.
We're excited to see PreComb recognized on this stage and look forward to supporting the team as they continue scaling their impact in oncology care.
More info about the awards and finalists here.
Organized by Sustainable Times, the RISE Awards recognize pioneering organizations that drive positive change across industries. PreComb is being honored alongside fellow finalists 2cureX and Nurtify for its transformative work in precision oncology.
PreComb's platform predicts patient drug response to help clinicians tailor cancer treatments with greater confidence. By reducing the time, cost, and uncertainty that often accompany treatment selection, PreComb is making personalized oncology more accessible and actionable for patients who need it most.
We're excited to see PreComb recognized on this stage and look forward to supporting the team as they continue scaling their impact in oncology care.
More info about the awards and finalists here.